BMC Complementary and Alternative Medicine Publishes Ambrotose AO® Supplement Clinical Study
A study published in BMC Complementary and Alternative Medicine demonstrated that Ambrotose AO capsules significantly increased serum oxygen radical absorbance capacity (ORAC) in healthy adults by 36.6% .* † The five-week combined Phase 1 and 2 open label, forced titration dose response study provides additional evidence that Ambrotose AO® capsules appear to be safe and are most effective at 4 capsules/day. The study was led by Professor Stephen Myers, PhD, BMed, ND, Director of the Australian Centre for Complementary Medicine Education and Research (ACCMER), a unique joint venture of the University of Queensland and Southern Cross University (SCU) and the NatMed-Research Unit, Research Cluster for Health and Wellbeing (NRU-RCHW), SCU, Lismore, AU. Co-authors included Dr. Lesley Stevenson (ACCM and the New Zealand Institute for Plant and Food Research Limited, Aukland, NZ); Drs. Phillip A. Cheras and Joan O’Connor (ACCM, NRU-RCHW); Dr. Lyndon Brooks (NRU-RCHW and Graduate Research College [GRC], SCU); Margaret Rolfe (GRC, SCU); Paul Connelan (ACCM, and the Centre for Phytochemistry and Pharmacology [CPP], SCU); and Dr. Carol Morris (CPP).
- Myers SP, Stevenson L, Cheras PA, et al. (2010) A forced titration study of the antioxidant and immunomodulatory effects of Ambrotose AO supplement. BMC Comp Alt Med 10, doi: 10.1186/1472-6882-10-16.